Xencor, Inc. (NASDAQ:XNCR – Free Report)’s share price reached a new 52-week low on Wednesday . The company traded as low as $24.43 and last traded at $24.52, with a volume of 46193 shares. The stock had previously closed at $24.90. Analysts Set New Price Targets A number of research firms have recently weighed in […]
Item 5.07. Submission of Matters to a Vote of Security Holders.
On June 14, 2023, Xencor, Inc. held its 2023 Annual Meeting of
Stockholders. A total of 58,351,294 shares of the Company s common. | June 15, 2023
StockNews.com started coverage on shares of Xencor (NASDAQ:XNCR – Get Rating) in a report issued on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on XNCR. SVB Leerink reaffirmed an outperform rating on shares of Xencor in a research note on Thursday, February […]
Bank of America began coverage on shares of Xencor (NASDAQ:XNCR – Get Rating) in a report released on Friday, The Fly reports. The firm issued a buy rating and a $42.00 price objective on the biopharmaceutical company’s stock. Several other equities research analysts also recently issued reports on the company. EF Hutton Acquisition Co. I […]
EFG Asset Management Americas Corp. trimmed its position in shares of Xencor, Inc. (NASDAQ:XNCR – Get Rating) by 5.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,010 shares of the biopharmaceutical company’s stock after selling 788 shares during […]